| Ytd | -7.89% | |
| 1y | 60.57% |
| Open | 9.37 | Prev Close | 9.28 | Low | 9.34 | High | 9.60 | Mkt Cap | 849.57M |
| Vol | 736.56K | Avg Vol | 1.80M | EPS | -3.35 | P/E | -2.86 | Forward P/E | -4.41 |
| Beta | 0.35 | Short Ratio | 7.94 | Inst. Own | 96.84% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 10.18 | 200-d Avg | 9.64 | 1yr Est | 31.17 |
SAN DIEGO, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a b
SAN DIEGO, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical
– Response rates up to 50% across evaluated dose levels and median PFS of 13 months observed in pre-
– Oral presentation will feature updated data from the FIT-001 Phase 1a study of darlifarnib plus ca
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly ear
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Thursday